La prevenzione dell'epatopatia nel bambino emofilico.

Translated title of the contribution: The prevention of liver disease in the hemophilic child

V. Carnelli, I. Serafini, L. Simoni, G. A. Moroni, P. Giulotto, M. Colombo

Research output: Contribution to journalArticle

Abstract

The modern replacement therapy of inherited bleeding disorders has proved to be a major advance in the management of haemophilic children. However, the haemophiliacs, early treated with commercial clotting factor concentrates obtained from large amounts of plasma, are exposed to blood borne viruses responsible for post-transfusion hepatitis (PTH) and for their possible harmful long-term sequelae. Infact high prevalence of infection with hepatitis B virus, non-A, non-B agents, delta agent has been documented among haemophilic children. In this study we analyze the measures of surveillance at present available in order to reduce the risk of PTH in young haemophilic patients. Among these measures of prevention we point out the magnitude of administrating hepatitis B vaccine to susceptible children and of using antihaemophilic factor heat-treated to reduce infectivity in those children who have never been treated and without signs of active viral infections.

Original languageItalian
Pages (from-to)41-47
Number of pages7
JournalPediatria Medica e Chirurgica
Volume5
Issue number3
Publication statusPublished - May 1983

Fingerprint

Liver Diseases
Hepatitis
Hepatitis Delta Virus
Hepatitis B Vaccines
Blood Coagulation Factors
Virus Diseases
Hepatitis B virus
Hot Temperature
Hemorrhage
Viruses
Infection
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Carnelli, V., Serafini, I., Simoni, L., Moroni, G. A., Giulotto, P., & Colombo, M. (1983). La prevenzione dell'epatopatia nel bambino emofilico. Pediatria Medica e Chirurgica, 5(3), 41-47.

La prevenzione dell'epatopatia nel bambino emofilico. / Carnelli, V.; Serafini, I.; Simoni, L.; Moroni, G. A.; Giulotto, P.; Colombo, M.

In: Pediatria Medica e Chirurgica, Vol. 5, No. 3, 05.1983, p. 41-47.

Research output: Contribution to journalArticle

Carnelli, V, Serafini, I, Simoni, L, Moroni, GA, Giulotto, P & Colombo, M 1983, 'La prevenzione dell'epatopatia nel bambino emofilico.', Pediatria Medica e Chirurgica, vol. 5, no. 3, pp. 41-47.
Carnelli V, Serafini I, Simoni L, Moroni GA, Giulotto P, Colombo M. La prevenzione dell'epatopatia nel bambino emofilico. Pediatria Medica e Chirurgica. 1983 May;5(3):41-47.
Carnelli, V. ; Serafini, I. ; Simoni, L. ; Moroni, G. A. ; Giulotto, P. ; Colombo, M. / La prevenzione dell'epatopatia nel bambino emofilico. In: Pediatria Medica e Chirurgica. 1983 ; Vol. 5, No. 3. pp. 41-47.
@article{ffec6a1250004eddb9b6f278c6fa5308,
title = "La prevenzione dell'epatopatia nel bambino emofilico.",
abstract = "The modern replacement therapy of inherited bleeding disorders has proved to be a major advance in the management of haemophilic children. However, the haemophiliacs, early treated with commercial clotting factor concentrates obtained from large amounts of plasma, are exposed to blood borne viruses responsible for post-transfusion hepatitis (PTH) and for their possible harmful long-term sequelae. Infact high prevalence of infection with hepatitis B virus, non-A, non-B agents, delta agent has been documented among haemophilic children. In this study we analyze the measures of surveillance at present available in order to reduce the risk of PTH in young haemophilic patients. Among these measures of prevention we point out the magnitude of administrating hepatitis B vaccine to susceptible children and of using antihaemophilic factor heat-treated to reduce infectivity in those children who have never been treated and without signs of active viral infections.",
author = "V. Carnelli and I. Serafini and L. Simoni and Moroni, {G. A.} and P. Giulotto and M. Colombo",
year = "1983",
month = "5",
language = "Italian",
volume = "5",
pages = "41--47",
journal = "Pediatria Medica e Chirurgica",
issn = "0391-5387",
publisher = "Vicenza Pediatria Medica E Chirurgica",
number = "3",

}

TY - JOUR

T1 - La prevenzione dell'epatopatia nel bambino emofilico.

AU - Carnelli, V.

AU - Serafini, I.

AU - Simoni, L.

AU - Moroni, G. A.

AU - Giulotto, P.

AU - Colombo, M.

PY - 1983/5

Y1 - 1983/5

N2 - The modern replacement therapy of inherited bleeding disorders has proved to be a major advance in the management of haemophilic children. However, the haemophiliacs, early treated with commercial clotting factor concentrates obtained from large amounts of plasma, are exposed to blood borne viruses responsible for post-transfusion hepatitis (PTH) and for their possible harmful long-term sequelae. Infact high prevalence of infection with hepatitis B virus, non-A, non-B agents, delta agent has been documented among haemophilic children. In this study we analyze the measures of surveillance at present available in order to reduce the risk of PTH in young haemophilic patients. Among these measures of prevention we point out the magnitude of administrating hepatitis B vaccine to susceptible children and of using antihaemophilic factor heat-treated to reduce infectivity in those children who have never been treated and without signs of active viral infections.

AB - The modern replacement therapy of inherited bleeding disorders has proved to be a major advance in the management of haemophilic children. However, the haemophiliacs, early treated with commercial clotting factor concentrates obtained from large amounts of plasma, are exposed to blood borne viruses responsible for post-transfusion hepatitis (PTH) and for their possible harmful long-term sequelae. Infact high prevalence of infection with hepatitis B virus, non-A, non-B agents, delta agent has been documented among haemophilic children. In this study we analyze the measures of surveillance at present available in order to reduce the risk of PTH in young haemophilic patients. Among these measures of prevention we point out the magnitude of administrating hepatitis B vaccine to susceptible children and of using antihaemophilic factor heat-treated to reduce infectivity in those children who have never been treated and without signs of active viral infections.

UR - http://www.scopus.com/inward/record.url?scp=0020753624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020753624&partnerID=8YFLogxK

M3 - Articolo

VL - 5

SP - 41

EP - 47

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 3

ER -